Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study shows booster vaccinations against SARS-CoV-2 effective but protection wanes rapidly

A recent study posted to medRxiv* assessed the effectiveness of primary and booster vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the Netherlands.

11 Jan 2023

Bivalent boosters tested against all SARS-CoV-2 Omicron lineages

In a recent study posted to the bioRxiv* preprint server, researchers in the United States assessed the impact of the bivalent messenger ribonucleic acid (mRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine on the antibody-mediated neutralization of the SARS-CoV-2 Omicron lineages.

11 Jan 2023

COVID-19 outcomes in Rituximab treated patients

A new report throws light on SARS-CoV-2 breakthrough infections in patients with certain joint diseases or musculoskeletal conditions who are on rituximab and compares the severity of COVID-19 outcomes in these patients whilst identifying potential risk factors for severe outcomes.

11 Jan 2023

Did people use mental health services more during the COVID-19 pandemic?

Researchers explored the utilization rates of mental health services among adults during the coronavirus disease 2019 (COVID-19) pandemic.

11 Jan 2023

Researchers study congenital abnormalities after COVID-19 infection and vaccination

Researchers compared the significant congenital abnormalities observed after coronavirus disease 2019 (COVID-19) infection and vaccination.

11 Jan 2023

2022: a year in MIS-C research

In a recent review published in Nature Reviews Rheumatology, researchers reviewed existing data on the multisystem inflammatory syndrome in children (or MIS-C).

11 Jan 2023

Lifestyle and genetic factors influence risk of cardiovascular complications after COVID-19

Researchers examined the contribution of lifestyle and genetic factors to cardiovascular and thromboembolic event (CVE) risk following coronavirus disease 2019 (COVID-19).

11 Jan 2023

Real-world effectiveness of the bivalent vaccine for preventing COVID-19 hospitalizations in non-hospitalized subjects

Researchers investigated the efficacy of a booster dose of the bivalent mRNA COVID-19 vaccine in preventing severe outcomes during SARS-CoV-2 infections.

11 Jan 2023

Review shows metformin usage to be associated with better COVID-19 outcomes

Researchers reported on the potential association between metformin usage and coronavirus disease 2019 (COVID-19) outcomes.

11 Jan 2023

Study suggests many symptoms are more common after COVID-19 infection, but only a few are commonly associated with a long COVID diagnosis

Researchers compared symptoms in patients with and without prior COVID-19 history and investigated symptoms associated with long COVID diagnosis in the UK.

11 Jan 2023

MALAT1 suppression is a hallmark of tissue and peripheral proliferative T cells in COVID-19

In a recent study posted to the medRxiv* preprint server, researchers in the United Kingdom investigated lncRNA (long non-coding ribonucleic acids) expression in coronavirus disease 2019 (COVID-19) T lymphocyte transcriptomes.

10 Jan 2023

MIS-C more common and severe than previously thought

In a recent study published in the JAMA Network Open journal, researchers compared the characteristics of multisystem inflammatory syndrome in children (MIS-C) and coronavirus disease 2019 (COVID-19).

10 Jan 2023

Spike protein mutations in Omicron subvariants increase their susceptibility to reductive cleavage of disulfide bonds

Researchers discovered that the spike protein of SARS-CoV-2 is susceptible to cleavage at the disulfide bonds, and the vulnerability to reductive cleavage varies across variants, with the Omicron variant family being highly susceptible to reduction.

10 Jan 2023

Study explores incidence, severity, and long COVID associations of SARS-CoV-2 reinfections

Researchers used electronic health records to characterize the incidence, biomarkers, attributes, and severity of SARS-CoV-2 reinfections and evaluated the association between reinfections and long coronavirus disease (COVID).

10 Jan 2023

Researchers review bacteriophage treatment

Researchers presented an overview of bacteriophage treatment, including mechanisms, types, design and applications of bacteriophage therapy.

10 Jan 2023

What were the risks and patterns of childhood deaths before and during the COVID-19 pandemic?

A new study describes the pattern of childhood deaths over 2019-21, the first two years of the pandemic, hoping to help identify the risks associated with these events.

10 Jan 2023

Profound immune escape by SARS-CoV-2 XBB.1 even after 4 vaccine doses

In a recent correspondence published in The Lancet Infectious Diseases journal, researchers in Germany assessed the neutralization sensitivity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) XBB.1 lineage.

9 Jan 2023

Group A streptococcal infections increased in England in 2022

In a recent study published in the journal Eurosurveillance, researchers investigated the latest increase in cases of invasive group A streptococcal (iGAS) infection among children in England below the age of 15 to understand the clinical presentations of iGAS as well as the incidence of co-infections with respiratory viruses.

9 Jan 2023

Study suggests that long-COVID is associated with physical inactivity

In a recent study published in the Scientific Reports journal, researchers in Brazil assessed the association between post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC) and physical inactivity.

9 Jan 2023

Deletions in the antigenic regions in SARS-CoV-2 increase transmission and immune evasion ability

A recent study published in the journal Scientific Reports examined the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) whole genome data to determine the deletion mutations around the spike protein region associated with increased transmission of the virus and identified an increase in the deletion-prone spike protein regions indicating an evolution strategy for immune escape.

9 Jan 2023

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study shows booster vaccinations against SARS-CoV-2 effective but protection wanes rapidly

Bivalent boosters tested against all SARS-CoV-2 Omicron lineages

COVID-19 outcomes in Rituximab treated patients

Did people use mental health services more during the COVID-19 pandemic?

Researchers study congenital abnormalities after COVID-19 infection and vaccination

2022: a year in MIS-C research

Lifestyle and genetic factors influence risk of cardiovascular complications after COVID-19

Real-world effectiveness of the bivalent vaccine for preventing COVID-19 hospitalizations in non-hospitalized subjects

Review shows metformin usage to be associated with better COVID-19 outcomes

Study suggests many symptoms are more common after COVID-19 infection, but only a few are commonly associated with a long COVID diagnosis

MALAT1 suppression is a hallmark of tissue and peripheral proliferative T cells in COVID-19

MIS-C more common and severe than previously thought

Spike protein mutations in Omicron subvariants increase their susceptibility to reductive cleavage of disulfide bonds

Study explores incidence, severity, and long COVID associations of SARS-CoV-2 reinfections

Researchers review bacteriophage treatment

What were the risks and patterns of childhood deaths before and during the COVID-19 pandemic?

Profound immune escape by SARS-CoV-2 XBB.1 even after 4 vaccine doses

Group A streptococcal infections increased in England in 2022

Study suggests that long-COVID is associated with physical inactivity

Deletions in the antigenic regions in SARS-CoV-2 increase transmission and immune evasion ability

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in